PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 47 filers reported holding PREVAIL THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $19,500,000 | -47.5% | 1,915,568 | -23.2% | 0.36% | -50.7% |
| Q2 2020 | $37,171,000 | -5.9% | 2,494,691 | -23.0% | 0.72% | -42.0% |
| Q1 2020 | $39,502,000 | -25.8% | 3,240,534 | -3.7% | 1.25% | -22.7% |
| Q4 2019 | $53,246,000 | +28.9% | 3,363,605 | 0.0% | 1.62% | -34.4% |
| Q3 2019 | $41,305,000 | +14.1% | 3,363,605 | +22.6% | 2.46% | +26.6% |
| Q2 2019 | $36,216,000 | – | 2,743,625 | – | 1.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 13,822,463 | $140,713,000 | 1.77% |
| Omega Fund Management, LLC | 187,538 | $1,909,000 | 0.52% |
| Boxer Capital, LLC | 1,123,105 | $11,433,000 | 0.40% |
| RA Capital Management | 1,915,568 | $19,500,000 | 0.36% |
| DAFNA Capital Management LLC | 75,000 | $764,000 | 0.25% |
| QVT Financial LP | 133,690 | $1,361,000 | 0.17% |
| Woodline Partners LP | 385,480 | $3,924,000 | 0.13% |
| Virtus ETF Advisers LLC | 19,773 | $201,000 | 0.10% |
| WEXFORD CAPITAL LP | 37,963 | $386,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 53,018 | $540,000 | 0.09% |